Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications

被引:158
|
作者
Berger, C
deMuret, A
Garaud, P
Chapet, S
Bourlier, P
ReynaudBougnoux, A
Dorval, E
deCalan, L
Huten, N
leFloch, O
Calais, G
机构
[1] HOP BRETONNEAU, CLIN ONCOL & RADIOTHERAPIE, TOURS, FRANCE
[2] HOP TROUSSEAU, ANAT PATHOL LAB, TOURS, FRANCE
[3] CHRU BRETONNEAU, LAB PATHOL CELLULAIRE, TOURS, FRANCE
[4] HOP TROUSSEAU, MALADIES APPAREIL DIGESTIF & NUTR, TOURS, FRANCE
[5] HOP TROUSSEAU, SERV CHIRURG DIGEST, TOURS, FRANCE
关键词
rectal carcinoma; preoperative radiotherapy; tumor downstaging; tumor sterilization; prognostic factors;
D O I
10.1016/S0360-3016(96)00577-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine predictive factors and prognostic value of tumor downstaging and tumor sterilization after preoperative RT for rectal cancer. Methods and Materials: Between 1977 and 1994, 167 patients with a histologically proven adenocarcinoma (70 T2, 65 T3, 29 T4, and 3 local recurrences) underwent preoperative RT. Median dose was 44 Gy (5-73 Gy). Surgery was performed in a mean time of 5 weeks after RT. Pathologic specimens have been reviewed by the same pathologist in order to specify the modified Astler Coller classification (MAC), and to quantify the residual tumor cell density (RTCD). Results: According to the MAC, there was 9 stage 0 (5%), 10 stage A (6%), 103 stage B1-B3 (62%), and 45 stage C1-C3 (27%) tumors. Seventeen percent and 56% of the patients who received a dose greater than or equal to 44 Gy had respectively a 0-A and a B tumor, compared to 4 and 69% in those who received a dose <44 Gy (p = 0.04). Tumor differentiation and a longer interval before surgery were significantly associated with a more frequent downstaging, and preoperative staging correlated well to the postoperative pathological findings. According to the RTCD, 62 tumors (37%) showed no or only rare foci of residual tumor cells (Group 1); 62 (37%) showed an intermediate RTCD (Group 2); and 43 (26%) a high RTCD (Group 3). No predictive factor of RTCD was statistically significant. In univariate analysis, postoperative staging was a significant prognostic factor, with corresponding 5-year overall survival rates in 0-A, B, and C stages of 92, 67, and 26% (p < 0.01). RTCD was not a prognostic factor. However, overall and disease-free survival rates for patients with complete pathologic response of 83% at 2 and 5 years suggested a better outcome in this subgroup of patients. Conclusion: The favorable influence of higher doses of preoperative RT on pathologic stage has been observed. Tumor differentiation, preoperative classification and time before surgery were the other predictive factors of tumor downstaging. However, there was no predictive factor of complete pathologic response. Even after preoperative RT, postoperative staging remained a prognostic factor. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 50 条
  • [41] Prognostic significance of tumor regression grade (TRG) after preoperative chemoradiation in rectal cancer
    Min, B.
    Kim, N.
    Ko, Y.
    Baek, S.
    Lee, K.
    Cho, C.
    Sohn, S.
    Pyo, J.
    Kim, H.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (05) : 775 - 776
  • [42] Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiation
    Jun-Sang, K.
    Shenglin, L.
    Jin-Man, K.
    Moon-June, C.
    Wan-Hee, Y.
    Kyu-Sang, S.
    Seung-Gu, Y.
    Jae-Sung, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 64 - 65
  • [43] Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy
    Kim, Jun-Sang
    Kim, Jin-Man
    Li, Shengjin
    Yoon, Wan-Hee
    Song, Kyu-Sang
    Kim, Ki-Hwan
    Yeo, Seung-Gu
    Nam, Ji Sook
    Cho, Moon-June
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 195 - 200
  • [44] A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation
    Kim, Nam Kyu
    Baik, Seung Hyuk
    Min, Byung Soh
    Pyo, Hong Ryull
    Choi, Yun Jung
    Kim, Hogeun
    Seong, Jinsil
    Keum, Ki Chang
    Rha, Sun Young
    Chung, Hyun Cheol
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 204 - 210
  • [45] MRI Predictive Factors for Tumor Response in Rectal Cancer Following Neoadjuvant Chemoradiation Therapy - Implications for Induction Chemotherapy?
    Yu, Stanley K. T.
    Tait, Diana
    Chau, Ian
    Brown, Gina
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (03): : 505 - 511
  • [46] Retrospective analysis of preoperative tumor marker levels in rectal cancer patients: Implications for diagnosis
    Li, Ming
    Yuan, Da-Hao
    Yang, Zhi
    Lu, Teng-Xiang
    Zhang, Lei
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2025, 17 (03):
  • [47] Bromodeoxyuridine Labeling Index as an Indicator of Early Tumor Response to Preoperative Radiotherapy in Patients with Rectal Cancer
    Anna Gasinska
    Jan Skolyszewski
    Tadeusz Popiela
    Piotr Richter
    Zbigniew Darasz
    Krystyna Nowak
    Joanna Niemiec
    Beata Biesaga
    Agnieszka Adamczyk
    Krzysztof Bucki
    Krzysztof Malecki
    Marian Reinfuss
    Teresa Kowalska
    Journal of Gastrointestinal Surgery, 2007, 11 : 520 - 528
  • [48] Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study
    Mirjolet, C.
    Charon-Barra, C.
    Ladoire, S.
    Arbez-Gindre, F.
    Bertaut, A.
    Ghiringhelli, F.
    Leroux, A.
    Peiffert, D.
    Borg, C.
    Bosset, J. F.
    Crehange, G.
    ONCOIMMUNOLOGY, 2018, 7 (03):
  • [49] Preoperative radiotherapy "short course" in rectal cancer in elder patient: Low impact on tumor regression
    Fattopace A.
    Canonico S.
    Guida A.
    Scala D.
    Ruffolo F.
    Cremona F.
    Pecori B.
    Guida C.
    Avallone A.
    Di Marzo M.
    Tatangelo F.
    Petrillo A.
    Marone P.
    Delrio P.
    BMC Geriatrics, 9 (Suppl 1)
  • [50] Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer
    Gasinska, Anna
    Skolyszewski, Jan
    Popiela, Tadeusz
    Richter, Piotr
    Darasz, Zbigniew
    Nowak, Krystyna
    Niemiec, Joanna
    Biesaga, Beata
    Adamczyk, Agnieszka
    Bucki, Krzysztof
    Malecki, Krzysztof
    Reinfuss, Marian
    Kowalska, Teresa
    JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (04) : 520 - 528